FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

781172008: Product containing albutrepenonacog alfa in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3745148018 Albutrepenonacog alfa-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3745149014 Product containing albutrepenonacog alfa in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3745148018 Albutrepenonacog alfa-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3745149014 Product containing albutrepenonacog alfa in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5587301000241117 produit contenant de l'albutrepenonacog alpha sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5587301000241117 produit contenant de l'albutrepenonacog alpha sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Albutrepenonacog alfa-containing product in parenteral dose form Is a Albutrepenonacog alfa-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Albutrepenonacog alfa-containing product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Albutrepenonacog alfa-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Albutrepenonacog alfa (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Albutrepenonacog alfa-containing product in parenteral dose form Is a Product containing coagulation factor IX in parenteral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Albutrepenonacog alfa-containing product in parenteral dose form Plays role Hemostatic therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Albutrepenonacog alfa-containing product in parenteral dose form Is a Product containing recombinant coagulation factor IX in parenteral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Albutrepenonacog alfa only product in parenteral dose form Is a True Albutrepenonacog alfa-containing product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start